Aurora Cannabis Sees Record Growth in Q2 2025
Company Announcements

Aurora Cannabis Sees Record Growth in Q2 2025

Aurora Cannabis (TSE:ACB) has released an update.

Aurora Cannabis reported impressive fiscal 2025 second-quarter results, achieving a record adjusted EBITDA of $10.1 million, marking a 210% increase year-over-year. The company saw a 29% rise in net revenue to $81.1 million, driven by strong growth in its global medical cannabis sector, particularly in markets like Australia and Germany. Aurora also maintained a robust balance sheet with significant cash reserves and a debt-free cannabis operation.

For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAurora Cannabis Financial Update Shows Asset Decline
TheFlyAurora Cannabis reports Q2 revenue C$81.1M vs. C$63.1M last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App